![Thomas R. Northenscold](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas R. Northenscold
Plus aucun poste en cours
Historique de carrière de Thomas R. Northenscold
Anciens postes connus de Thomas R. Northenscold
Sociétés | Poste | Début | Fin |
---|---|---|---|
Daig Corp.
![]() Daig Corp. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Daig Corp. is a company that manufactures specialty catheters. The company is based in Hopkins, MN. Daig was acquired by St. Jude Medical LLC, part of Abbott Laboratories from January 05, 2017 on May 31, 1996 for $439.60 million. | Directeur Administratif | 01/01/2001 | - |
Directeur Financier/CFO | 01/01/2001 | - | |
ST JUDE MEDICAL INC | Directeur Technique/Scientifique/R&D | 01/03/2003 | - |
Formation de Thomas R. Northenscold
Minnesota State University-Mankato | Undergraduate Degree |
University of Michigan | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 5 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 1 |
Undergraduate Degree | 1 |
Masters Business Admin | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
St. Jude Medical LLC
![]() St. Jude Medical LLC Medical SpecialtiesHealth Technology St. Jude Medical LLC develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. The company was founded by Manuel A. Villafana in 1976 and is headquartered in St. Paul, MN. | Health Technology |
Daig Corp.
![]() Daig Corp. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Daig Corp. is a company that manufactures specialty catheters. The company is based in Hopkins, MN. Daig was acquired by St. Jude Medical LLC, part of Abbott Laboratories from January 05, 2017 on May 31, 1996 for $439.60 million. | Health Technology |
- Bourse
- Insiders
- Thomas R. Northenscold
- Expérience